Cargando…

A Novel Strategy for Mechanism Based Computational Drug Discovery

Glioma, the common brain tumor, which arises from the glial cells, offers worse prognosis and therapy than any other tumors. Despite the genetic and pathological diversities of malignant gliomas, common signaling pathways that drive cellular proliferation, survival, invasion and angiogenesis have be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subha, Kalyaanamoorthy, Kumar, Gopal Ramesh, Rajalakshmi, Rajasekaran, Aravindhan, Ganesan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783289/ https://www.ncbi.nlm.nih.gov/pubmed/24179383 http://dx.doi.org/10.4137/BIC.S3720

Ejemplares similares

Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 main protease complexes reveal the role of lateral pocket in enhancing the ligand affinity
por: Weng, Ying Li, et al.
Publicado: (2021)

Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective
por: Chahal, Sandhya, et al.
Publicado: (2023)

hnRNP A/B Proteins: An Encyclopedic Assessment of Their Roles in Homeostasis and Disease
por: Thibault, Patricia A., et al.
Publicado: (2021)

Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction
por: Clarke, Joseph P., et al.
Publicado: (2023)

The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease
por: Tran, Norman, et al.
Publicado: (2023)

A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
por: Kalyaanamoorthy, Subha, et al.
Publicado: (2020)

Investigating the Theranostic Potential of Graphene Quantum Dots in Alzheimer’s Disease
por: Walton-Raaby, Max, et al.
Publicado: (2023)

TRPV1 channels as a newly identified target for vitamin D
por: Long, Wentong, et al.
Publicado: (2021)

GPCR_LigandClassify.py; a rigorous machine learning classifier for GPCR targeting compounds
por: Ahmed, Marawan, et al.
Publicado: (2021)

TaxKB: a knowledge base for new taxane-related drug discovery
por: Murugan, Kasi, et al.
Publicado: (2015)

Assessment for the identification of better HDAC inhibitor class through binding energy calculations and descriptor analysis
por: Subha, Kalyanamoorthy, et al.
Publicado: (2008)

Novel Strategies for Drug Discovery Based on Intrinsically Disordered Proteins (IDPs)
por: Wang, Jihua, et al.
Publicado: (2011)

Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
por: Konaklieva, Monika I., et al.
Publicado: (2023)

Identification of Dietary Bioflavonoids as Potential Inhibitors against KRAS G12D Mutant—Novel Insights from Computer-Aided Drug Discovery
por: Ramalingam, Prasanna Srinivasan, et al.
Publicado: (2023)

Novel Targets and Mechanisms in Antimicrobial Drug Discovery
por: Tondi, Donatella
Publicado: (2021)

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery
por: Ibrahim, Hany S., et al.
Publicado: (2021)

PROTACs: A novel strategy for cancer drug discovery and development
por: Han, Xin, et al.
Publicado: (2023)

ModelFinder: Fast Model Selection for Accurate Phylogenetic Estimates
por: Kalyaanamoorthy, Subha, et al.
Publicado: (2017)

Computer-aided drug discovery
por: Bajorath, Jürgen
Publicado: (2015)

Computational methods in drug discovery
por: Leelananda, Sumudu P, et al.
Publicado: (2016)

Computational Approaches for Drug Discovery
por: Brogi, Simone
Publicado: (2019)

New Strategies in Drug Discovery
por: Ohlstein, Eliot H., et al.
Publicado: (2006)

Strategies for senolytic drug discovery
por: Power, Helen, et al.
Publicado: (2023)

Strategies for translating proteomics discoveries into drug discovery for dementia
por: Halder, Aditi, et al.
Publicado: (2023)

Cell surface GRP78: a potential mechanism of therapeutic resistant tumors
por: Amaresan, Rajalakshmi, et al.
Publicado: (2023)

Computational discovery and experimental validation of novel drug targets in immuno-oncology
por: Levy, Ofer, et al.
Publicado: (2015)

CanGeneBase (CGB) ‐ a database on cancer related genes
por: Kumar, Gopal Ramesh, et al.
Publicado: (2009)

Editorial: Computational drug discovery for emerging viral infections
por: Skariyachan, Sinosh, et al.
Publicado: (2023)

Computational discovery of transcription factors associated with drug response
por: Hanson, C, et al.
Publicado: (2016)

Development of Computational Approaches with a Fragment-Based Drug Design Strategy: In Silico Hsp90 Inhibitors Discovery
por: León, Roberto, et al.
Publicado: (2021)

A minimum reporting standard for multiple sequence alignments
por: Wong, Thomas K F, et al.
Publicado: (2020)

Frontiers in Computational Chemistry for Drug Discovery
por: Luque, F. Javier
Publicado: (2018)

Towards reproducible computational drug discovery
por: Schaduangrat, Nalini, et al.
Publicado: (2020)

Chemoinformatics Strategies for Leishmaniasis Drug Discovery
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

In Silico Strategies in Tuberculosis Drug Discovery
por: Macalino, Stephani Joy Y., et al.
Publicado: (2020)

Dynamic template-assisted strategies in fragment-based drug discovery
por: Schmidt, Marco F., et al.
Publicado: (2009)

COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
por: Kumar, Sunny, et al.
Publicado: (2023)

Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain
por: Olson, Keith M., et al.
Publicado: (2017)

Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis Inducer
por: Eissa, Ibrahim H, et al.
Publicado: (2023)

Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
por: Pandey, Swaroop Kumar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_flmb88skp8jt3r5v3v1m9v1163